Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)
Italy
· Delayed Price · Currency is EUR 288.00
-13.70 (-4.54%)
At close: May 2, 2025
Madrigal Pharmaceuticals Revenue
Madrigal Pharmaceuticals had revenue of $137.25M USD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $317.38M. In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M.
Revenue (ttm)
$317.38M
Revenue Growth
n/a
P/S Ratio
20.45
Revenue / Employee
$601.10K
Employees
528
Market Cap
6.01B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Intesa Sanpaolo | 25.42B |
| UniCredit | 23.99B |
| Enel SpA | 78.35B |
| Ferrari | 6.88B |
| Assicurazioni Generali | 55.30B |
| Eni S.p.A. | 90.96B |
| Leonardo S.p.a. | 18.26B |
| Stellantis | 156.88B |